PT-141 10 mg

PT-141 / Bremelanotide (10mg) – Central Nervous System Melanocortin Agonist

Investigate central pathways of libido and sexual response with PT-141 (Bremelanotide), a synthetic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH). Unlike traditional agents that target the vascular system, PT-141 works directly through the central nervous system by activating melanocortin receptors (primarily MC3R and MC4R) in the brain to modulate sexual motivation, arousal, and erectile function.

Key Benefits:

• Central Action Pathway: Acts directly on brain receptors rather than relying on vascular dilation.
• Supports Libido & Sexual Function: Evaluated for enhancing sexual desire, arousal, and satisfaction parameters in both male and female models.
• Melanocortin Receptor Binding: Highly targeted activation of MC3R and MC4R pathways associated with motivation and reward signaling.

Ideal For:

• Central nervous system sexual dysfunction research
• Melanocortin receptor (MC3R/MC4R) pathways studies
• Libido and sexual arousal behavioral modeling
• Hypoactive sexual desire disorder (HSDD) research

Typical research dosing ranges from 1 mg to 2 mg per administration (administered as needed, approximately 45 minutes to 2 hours prior to study observation).

Add 2mL of bacteriostatic water to get a solution that is 5mg/mL, such that every 0.2mL (20 units on an insulin syringe) is equal to 1mg of PT-141.

Store unmixed vials in a cool, dark place away from direct light. Once reconstituted, this product must be refrigerated between 2°C – 8°C (36°F – 46°F) and used within 30 days.